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Introduction Methods 
There is now a large body of evidence sug- 
gesting a close interaction between the central 
nervous system and the immune system. More 
specifically, immunological abnormalities have 
been described in relation to psychological stress 
(Jemrnott and Locke 1984) and in patients with 
psychiatric illness (DeLisi and Crow 1986). We 
have earlier reported a decrease in mitogen-in- 
duced lymphocyte proliferation in hospitalized 
depressed patients compared to normal controls 
(Kronfol et al. 1983). These findings have been 
replicated by independent investigators (Schlei- 
fer et al. 1984). Negative life events and depres- 
sion have been associated with immunological 
impairment, as evidenced by decreased respon- 
sivity to mitogen stimulation and reduced nat- 
ural killer cell activity (Bartmp et al. 1977; Locke 
et al. 1984). On the other hand, to the best of 
our knowledge, the immune status of patients 
with manic illness has never been investigated. 
We now report an impairment in immune reg- 
ulation in manic patients similar to what has 
been described in patients with major depres- 
sion. 
Subjects 
Three groups of subjects were identified: acutely 
manic patients (n = II), deteriorated schizo- 
phrenic controls (n = 22), and normal controls 
(n = 37). Both the manic patients and the 
schizophrenic patients were hospitalized at the 
University of Iowa Psychiatric Hospital. Psy- 
chiatric diagnoses were made in accordance with 
DSM-III criteria. Mean ages (+ SD) for the 
three groups were as follows: manic patients 
36.5 2 13.9, schizophrenic controls 30.0 + 
8.8, and normal controls 31.3 ? 9.0. These 
differences were not statistically significant (F 
= 1.68, p NS) The sex distribution of the three 
groups was as follows: manic patients 6 men, 
5 women, schizophrenic controls 18 men, 4 
women, normal controls 19 men, 18 women. 
These differences in sex distribution were not 
statistically signilicant either (x2 = 5.66, p NS). 
Patients and controls were free of medical illness 
or drugs known to interfere with immune func- 
tion. Psychotropic medications, however, were 
not considered as exclusion criteria. The im- 
munological assays on both the manic patients 
and the schizophrenic controls were done while 
these patients were acutely ill, usually within 
10 days of admission to the hospital. Normal 
controls were healthy volunteers who were free 
of medical and psychiatric illness and were not 
taking medications at the time of the study. 
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Procedures 
Twenty milliliters of blood was drawn from each 
subject between 8:00 and 9:00 AM. Whenever 
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possible, blood samples from subjects in all three 
groups were assayed together to control for day- 
to-day variation in the assay. As this was not 
always possible, a blood sample from a normal 
control was therefore included in every assay. 
A total white blood cell (WBC) count and a 
differential were done using standard proce- 
dures. Blood was then centrifuged over Ficoll- 
Hypaque and the lymphocytes were separated 
for culture or surface marker analysis. Lym- 
phocyte cultures were then established in tri- 
plicate, as previously described (Kronfol et al. 
1983). To each well, one of the following mi- 
togens was added: no mitogen for background 
transformations (blank); phytohemagglutin-P 
(PHA), 2.5 pg/ml; concanavalin-A (Con-A), 10 
kg/ml; and pokeweed mitogen (PWM), 2.5 
pg/ml. The cultures were kept for 4 days prior 
to addition of tritiated thymidine and harvesting. 
Tritiated thymidine uptake was then measured 
with a scintillation counter. Mean scintillation 
counts per minute (cpm) were calculated for 
each mitogen, and the three groups were com- 
pared. For the surface marker analyses, lym- 
phocytes from each subject were washed several 
times and incubated separately with one of the 
following commercially available monoclonal 
antibodies (Coulter Immunology, Hialeah, FL): 
B, for total B lymphocytes, T,, for total T lym- 
phocytes, T4 for helper T lymphocytes, and TS 
for suppressor T lymphocytes. The cells were 
then washed again and incubated with a fluo- 
rescein-conjugated second antibody (GAM-FIX; 
Coulter Immunology). The frequency (percent- 
age) of each cell type was then determined in- 
directly with fluorescent microscopy. Differ- 
ences between the three groups were analyzed 
with analysis of variance (ANOVA). This pro- 
cedure is relatively powerful with respect to un- 
equal sample sizes. Whenever an overall sig- 
nificance was found (i.e., p < 0.05), pairwise 
comparison follow-up tests were done using the 
Duncan multiple range test. 
Results 
A comparison of the different immune variables 
in manic patients, schizophrenic controls, and 
normal controls is presented in Table 1. There 
were no significant differences in either total 
WBC counts, total lymphocyte counts, or any 
of the lymphocyte subsets among the three groups. 
Results of the mitogen stimulation assays, on 
the other hand, revealed significant reductions 
in lymphocyte responsivity to the mitogens PHA 
and Con-A in manic patients compared to both 
schizophrenic controls and normal controls. 
However, the latter two groups did not signif- 
icantly differ from each other. Responses to PWM 
were lowest in the manic group, but overall 
significance was not obtained, partly because of 
the large standard deviation observed in the 
schizophrenic group. 
Discussion 
Our results indicate a decrease in mitogen-in- 
duced lymphocyte proliferation in manic pa- 
tients in comparison to schizophrenic controls 
and normal controls. Lymphocyte numbers and 
lymphocyte subsets, on the other hand, did not 
significantly differ among the groups. The re- 
duction in lymphocyte responsivity to the mi- 
togens PHA and Con-A suggests an impairment 
in cell-mediated immune response, as these mi- 
togens are known to stimulate mostly T cells. 
The response to PWM, a mostly B-cell mitogen , 
although lower in manic patients, was not sig- 
nificantly different from normal controls. 
Several factors, such as age, sex, diurnal 
variation, medical illness, and drugs, should be 
considered in interpreting our results. There were 
no significant differences in age or sex distri- 
bution among the groups. All blood samples 
were drawn at the same time of the day to control 
for possible diurnal variation. Patients with 
medical illness or drugs known to interfere with 
immune function were excluded. All manic and 
schizophrenic patients were hospitalized on the 
same unit, so the effects of hospitalization and 
the milieu were the same for these two groups. 
All but two of the manic patients were on med- 
ications: three were on lithium, three were on 
neuroleptics , and three were on both lithium and 
neuroleptics. All but six of the schizophrenic 
controls were also on medications: 14 were on 
neuroleptics and 2 were on other drugs. Results 
of the unmedicated manic patients were similar 
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Table 1. Immunological Variables in Manic Patients, Schizophrenic Controls, and Normal Controls” 
Schizophrenic Normal 
controls controls 









PHA (2.5 p@ml) 
Con-A (10 &nl) 
PWM (2.5 /@ml) 
7,867 2 2,598 7,797 ” 2.405 6,787 f 1,779 
2,303 f 872 2,414 2 1,136 2,540 ” 629 
11.1 * 5.0 10.3 k 6.2 7.6 + 5.7 
59.4 2 9.7 67.0 2 10.7 66.6 f 9.5 
41.0 zk 8.1 41.2 k 8.4 39.1 f 6.4 
23.2 f 4.0 22.2 r 8.6 25.3 k 6.0 
1.81 f 0.48 2.04 f 0.71 1.63 2 0.48 
719 * 409 1,032 f 406 940 2 702 
121,976 2 36,055 164,764 2 64,023 177,773 + 66,867 
76,501 2 24,534 137,844 _’ 65,032 151,067 f 84,373 












“RWdt8 a CX&UWd Bs m.S”S f SD. 
bStatistical analyses are done with ANOVA 
to those of the medicated manic patients in that 
they showed much lower lymphocytic responses 
than either the unmedicated schizophrenic con- 
trols or the normal controls. Mean mitogenic 
responses to PHA, Con-A, and PWM in the 
unmedicated manic patients were 106,773, 
73,534, and 84,144, respectively. The corre- 
sponding values in the unmedicated schizo- 
phrenic controls were 203,452, 156,607, and 
116,008, respectively. It is therefore unlikely 
that the differences in mitogenic responses be- 
tween the groups is the mere result of medica- 
tions. Rather, we propose that mania is asso- 
ciated with an impairment in cell-mediated 
immunity as reflected by a reduced in vitro lym- 
phocyte response to mitogen stimulation. The 
effects of psychotropic medications on the im- 
mune system, however, need further investi- 
gation . 
In summary, we compared the frequency of 
different lymphocyte subsets and lymphocyte 
mitogenic activity in manic patients, schizo- 
phrenic controls, and normal controls. We found 
a significant reduction in mitogenic activity in 
the manic group, which is suggestive of an im- 
pairment of cellular immunity in mania. Our 
sample size, however, is relatively small, and 
the potential effects of psychotropic medications 
need further elucidation, These preliminary re- 
sults should therefore be confirmed in a larger 
sample with more drug-free manic patients. The 
mechanism(s) of immunosuppression should also 
be investigated. 
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